- Changpeng Zhao shared his enthusiasm for exploring the wider space of DeSci.
- According to a tweet, Binance’s former CEO intends to invest crypto in biotech, fostering research.
- Messari CEO Ryan Selkis and the Etica protocol acknowledged Zhao’s interest in DeSci.
Changpeng Zhao, the former CEO of Binance, has hinted at his initiative to explore the wider space of decentralized science (DeSci). In his recent tweet, Zhao unveiled his thoughts on the ways in which crypto and biotechnology could go hand in hand.
Been reading about biotech, thinking about how to use crypto to accelerate research funding there.Keep building!
— CZ BNB (@cz_binance) November 27, 2023
Shedding light on his potential step to invest cryptocurrencies in biotechnology to “accelerate funding” in biotech research, the former Binance CEO signaled his future plans following his departure from Binance.
Zhao’s enthusiasm for collaborating in crypto with biotech has received great acceptance from both spaces. Etica, the protocol that supports open-source research in DeSci, shared their immense pleasure in witnessing major crypto figures stepping into the DeSci space.
They cit…
The post Changpeng Zhao Intends To Invest Crypto in Biotech to Foster Research appeared first on Coin Edition.